Major review finds 34% reduction in suicide risk following electroconvulsive therapy in patients with severe depression
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Nov-2025 12:11 ET (15-Nov-2025 17:11 GMT/UTC)
A newly published analysis reveals that individuals with severe depression who received electroconvulsive therapy (ECT) were 34% less likely to die by suicide compared to those treated with standard alternatives such as anti-depressant medication. This comprehensive meta-analysis is the first of its kind to demonstrate such a significant reduction in suicide risk linked to ECT. The findings also show that patients receiving ECT had 30% fewer deaths from any cause, suggesting broader health benefits beyond mental health.
In a new paper published in the journal Psychological Review, Cory Cobb, PhD, assistant professor in the Department of Health Behavior at the Texas A&M University School of Public Health, and colleagues from the University of Texas at Austin, proposed a cultural continuity hypothesis stating that humans are universally motivated to retain and preserve key parts of their cultures across time and space.
For the study, published in Safety and Health at Work, researchers explored how earned sick leave laws impact rates of reportable nonfatal illness or injury across major industry categories. They obtained annual state rates of occupational nonfatal illness or injury reports and earned sick leave policy data. They found that states that implemented earned sick leave prior to 2019 saw a marginally significant increase in the rates of illness and injury reporting across industries after these policies were introduced.
The American Society of Echocardiography (ASE) and Cardiovascular Research Foundation® (CRF®) are pleased to announce a new educational collaboration to foster shared learning, drive innovation, and strengthen connections across the cardiovascular community.
In a new study from Boston University Chobanian & Avedisian School of Medicine, researchers have identified a protein called non-structural protein 15 (nsp15) that plays a key role in helping SARS-CoV-2 hide from the body’s defenses by suppressing the production of viral double-stranded (dsRNA), leading to increased viral replication while limiting the body’s immune response.